Inovio Pharmaceuticals, Inc.
NASDAQ:INO
1.84 (USD) • At close December 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Inovio Pharmaceuticals, Inc. |
Symbool | INO |
Munteenheid | USD |
Prijs | 1.84 |
Beurswaarde | 66,424,000 |
Dividendpercentage | 0% |
52-weken bereik | 1.74 - 14.75 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Jacqueline E. Shea Ph.D. |
Website | https://www.inovio.com |
An error occurred while fetching data.
Over Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)